Mike Sjaastad
Director of Business Development at Araceli Biosciences | Visionary executive in corporate development, culture and business growth. Start-up Mentor and Advisor.
- Role
- Director of Business Development at Araceli Bio at Araceli Biosciences
- Location
- Lake Oswego, OR, US
- LinkedIn followers
- 500 followers
About Mike Sjaastad
Extensive experience in pharma, biotech, academia, focused on commercialization of novel technologies and applications development for drug discovery, cell biology, genomics, immunology, and innovative research. Insightful, resourceful, visionary, and self-directed executive and advisor, with demonstrated success in corporate development, alliance management, partnerships, business growth, product positioning, within life sciences. Background and expertise in M&A, technology prospecting and integration, applications development, new project implementation, business expansion, multiple product platform launches, scientific research, and translating corporate goals into strategic initiatives that drive transformation and revenue. Forward-thinking, solutions-focused, and results-driven, with excellent interpersonal communication skills, cross-functional team leadership and collaboration, robust task ownership, and a strong work ethic. Resolves issues effectively, executes time-critical decisions, drives results, and achieves key deliverables. KEY ACCOMPLISHMENTS: • Held a strategic role in multiple successful life science technology companies with a combined exit tally of nearly $2 Billion. • Achieved YOY increase in revenue through collaboration with the CEO to drive structural and cultural transition, and strategic positioning of a automation solutions provider; resulting a ~$200M exit. • Developed and Launched the ImageXpress™ High Content product line as an innovative pioneer in the high content imaging industry. • Launched IntelliCyt iCue high speed flow cytometer. IntelliCyt was acquired by Sartorius for ~$90M • Strategic market entry and technical advisor on Biotek Cytation Imager. Biotek was acquired by Agilent in excess of $1B CORE COMPETENCIES: Corporate Strategy Development | Business Analysis/Intelligence | Strategic Planning | Global Business Development | Requirements Analysis | Market Research | Competitive Analysis | Strategic Marketing | Sales | Commercialization Product Development/Positioning | Negotiations | Contracts | Performance Optimization | Budgets | M&A | Due Diligence | Intellectual Property | Technology Prospecting/Transfer/Integration Partnerships | Stakeholder Relationships | Alliance Management | Cross-Functional Team Leadership/Collaboration | Oncology | Immunology | Assay Development | Genomics | Cell Biology | Human Physiology Immunoassays | Proteomics | Drug Discovery Microscopy | Cellular Imaging | Applications Development | MS Office Suite |
Experience
Director of Business Development at Araceli Bio
Aug 2021 — Present · US
Education
Swarthmore College
Bachelor of Arts (B.A.), Biopsychology
Stanford University School of Medicine
Postdoctoral, Cell Biology and Immunology
University of California, Berkeley
Ph.D., Physiology/Cell Biology
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.